// App-Quantinova.ai

SAT0259 : TWO NOVEL DIAGNOSTIC BIOMARKERS OF CARTILAGE DEGRADATION AND CONNECTIVE TISSUE INFLAMMATION ARE PREDICTIVE OF DISEASE PROGRESSION IN ANKYLOSING SPONDYLITIS

Researchers

Presenter

  • A.C. Bay-Jensen

Principal Investigators

  • S. Wischuk

  • I. Byrjalsen

  • M.A. Karsdal

  • W.A. Maksymowych

Medical Centers

  • Division of Rheumatology, University of Alberta, Alberta, Canada

Locations

  • Canada

Companies

  • Nordic Bioscience A/

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Spondyloarthritis

  • Osteoarthritis

  • Inflammatory Arthritis

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • Methotrexate

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved